NASDAQ:KALV

Kalvista Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy KALV

*Your capital is at risk

$26.95

+0.0100 (+0.0371%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

KALV Prediction Chart

KALV Predictions History

Latest community submissions for KALV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
rombrento.346449	Oct 5, 2022	$6.17 +5.47%	$5.15	X	80.19%	0
rajatrathee15.346367	Oct 5, 2022	Bullish	$5.15	X	—	0
Sander Levi Djupvik Strømberg @SanderLeviDjupvikStrC3B8mberg.209675	Apr 16, 2021	$29.54 +20.82%	$24.45	X	79.18%	0
JS Pro	Apr 16, 2021	$25.64 +4.87%	$24.45	X	95.13%	0
JS Pro	Feb 12, 2021	$36.47 -14.33%	$42.57	X	85.67%	0
Carrie Carrie @CarrieCarrie.190826	Feb 12, 2021	Bearish	$42.57	X	—	0
Bashar Alshaar @BasharAlshaar.206407	Feb 12, 2021	$44.00 +3.36%	$42.57	X	96.64%	1
JS Pro	Feb 11, 2021	$32.96 -18.52%	$40.45	X	81.48%	0
Bashar Alshaar @BasharAlshaar.206407	Feb 11, 2021	$37.46 -7.39%	$40.45	X	92.61%	0
JS Pro	Oct 20, 2020	$15.03 -11.33%	$16.95	X	88.67%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KALV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT KALVISTA PHARMACEUTICALS INC

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by